Skip to main content
Log in

Acute myeloblastic leukemia following treatment with mitomycin C: a case report

  • Letter to the Editors
  • Mitomycin C, Myeloblastic Leukemia
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Doll DC, Wiess RB, Issel BF (1985) Mitomycin: ten years after approval for marketing. J Clin Oncol 3: 276–286

    Google Scholar 

  2. Henne T, Schmahl D (1985) Occurrence of second primary malignancies in man — a second look. Cancer Treat Rev 12: 77–94

    Google Scholar 

  3. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancer after treatment for Hodgkin's disease. N Engl J Med 318: 76–81

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burde, B., Haim, N., Gez, E. et al. Acute myeloblastic leukemia following treatment with mitomycin C: a case report. Cancer Chemother. Pharmacol. 24, 71 (1989). https://doi.org/10.1007/BF00254112

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254112

Keywords

Navigation